Domů › Rakovina (všechny typy) › North Carolina › Durham
Klinické studie Rakovina (všechny typy) v Durham, NC
58 studií pro Rakovina (všechny typy) hledá účastníky v lokalitách v Durham a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Probíhá náborFáze 1/2
- GSK Investigational Site, Durham
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Probíhá náborObservační studie
- The University of North Carolina Chapel Hill, Chapel Hill · Vzdálenost 10 mi
A Study of PHN-012 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1
- PHN-012-001 Site, Durham
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Probíhá náborFáze 3
- Duke University Medical Center, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Probíhá náborFáze 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
- University of North Carolina Hospitals at Hillsborough, Hillsborough · Vzdálenost 13 mi
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Probíhá náborFáze 3
- Duke University Medical Center - Duke Cancer Centre, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Probíhá náborFáze 3
- Quetzal Site 27, Chapel Hill · Vzdálenost 10 mi
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · Vzdálenost 7 mi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Probíhá náborFáze 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Probíhá náborFáze 2/3
- Duke University Medical Center, Durham
- The University of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
Digital Art Therapy for Young Cancer Survivors
Probíhá nábor
- Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
Probíhá náborFáze 1
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill · Vzdálenost 10 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Probíhá náborFáze 2
- University of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Probíhá náborFáze 1/2
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · Vzdálenost 10 mi
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Probíhá náborFáze 1
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Probíhá náborFáze 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · Vzdálenost 10 mi
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Probíhá náborFáze 3
- Duke Cancer Center, Durham
Project: Every Child for Younger Patients With Cancer
Probíhá náborObservační studie
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
Probíhá nábor
- University of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Probíhá náborFáze 3
- University of North Carolina Chapel Hill, Chapel Hill · Vzdálenost 10 mi
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Probíhá náborFáze 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Duke University, Durham
Behavioral Pain Intervention for Older Cancer Patients
Probíhá nábor
- Duke Cancer Network, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Probíhá náborFáze 1
- Duke Cancer Institute, Durham
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
Probíhá náborVítáni zdraví dobrovolníci
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Probíhá náborFáze 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Probíhá náborFáze 1/2
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · Vzdálenost 10 mi
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 1
- University of North Carolina /ID# 251203, Chapel Hill · Vzdálenost 10 mi
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Probíhá náborFáze 2
- Duke University Medical Center /ID# 279457, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Probíhá náborFáze 1
- Duke Cancer Center, Durham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Probíhá nábor
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Probíhá náborVítáni zdraví dobrovolníci
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · Vzdálenost 10 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Probíhá nábor
- Durham VA Medical Center, Durham, NC, Durham
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Probíhá náborObservační studie
- University of North Carolina, Chapel Hill · Vzdálenost 10 mi
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Probíhá náborFáze 1
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Probíhá náborFáze 1
- Duke Cancer Center /ID# 251975, Durham
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Probíhá náborFáze 2
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
Probíhá nábor
- Durham VA Medical Center, Durham, NC, Durham
Improving Outcomes in Early Menopause After Cancer
Probíhá nábor
- Duke Cancer Institute, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
Probíhá náborObservační studie
- University of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
UNC Metastatic Cancer Radiation Therapy Registry
Probíhá náborObservační studie
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · Vzdálenost 10 mi
Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors
Probíhá náborVítáni zdraví dobrovolníci
- Duke Cancer Institute, Durham
Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
Probíhá náborObservační studie
- UNC Hospitals, Chapel Hill · Vzdálenost 10 mi
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Probíhá náborFáze 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Probíhá nábor
- Durham VA Medical Center, Durham, NC, Durham
Rehabilitation Outcomes Study
Probíhá nábor
- The N.C. Cancer Hospital, Chapel Hill · Vzdálenost 10 mi
Cancer and Mild Cognitive Impairment Dyadic Intervention
Probíhá nábor
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Probíhá náborFáze 2
- University of North Carolina /ID# 233313, Chapel Hill · Vzdálenost 10 mi
GEMINI-NSCLC: NSCLC Biomarker Study
Probíhá náborObservační studie
- Duke University, Durham
- UNC, Chapel Hill · Vzdálenost 10 mi
Effectiveness of Central Oncology Navigation and the Use of an ORN
Probíhá nábor
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Probíhá nábor
- Duke Cancer Institute, Durham
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
Probíhá nábor
- Duke University School of Medicine, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Chapel Hill · Vzdálenost 10 mi
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Probíhá náborObservační studie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Vzdálenost 10 mi
Young Adult Infusion Space Experience Satisfaction Survey
Probíhá náborObservační studie
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
UNC Pleural Fluid Registry
Probíhá náborObservační studie
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
A Study of NX-1607 in Adults With Advanced Malignancies
Probíhá náborFáze 1
- University of North Carolina, Chapel Hill · Vzdálenost 10 mi
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Probíhá nábor
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · Vzdálenost 13 mi
Studie Rakovina (všechny typy) v jiných městech
- Houston, TX121 studií
- New York City, NY110 studií
- Boston, MA86 studií
- Los Angeles, CA73 studií
- Nashville, TN65 studií
- Philadelphia, PA59 studií
- Washington, DC58 studií
- Chicago, IL51 studií
- Seattle, WA49 studií
- Atlanta, GA49 studií
- Arlington, VA48 studií
- St. Louis, MO46 studií
Další studie v Durham
- Rakovina prsu63 studií
- Nemalobuněčný plicní karcinom39 studií
- Mnohočetný myelom37 studií
- Metastatický karcinom33 studií
- Akutní myeloidní leukemie33 studií
- Rakovina plic32 studií
- Rakovina prostaty32 studií
- Kolorektální karcinom28 studií
- Chronická lymfocytární leukemie27 studií
- Rakovina vaječníků27 studií
- Srdeční selhání26 studií
- Rakovina slinivky břišní24 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.